
HEPARCHEM 25000 IU
| Pack |
|---|
HEPARCHEM 25000 IU functions as a potent heparin solution, which doctors use to treat and prevent thromboembolic disorders. This injectable solution functions as a primary tool for cardiovascular medicine and emergency care because it enables doctors to control patients’ blood clotting systems during critical medical procedures. The active constituent of HEPARCHEM 25000 IU is Heparin Sodium, which functions as a strong anticoagulant that prevents blood coagulation through indirect effects on the coagulation cascade. The process works by antithrombin III binding to activated clotting factors, which results in rapid factor IIa (Thrombin) and Factor Xa neutralization. The substance blocks fibrinogen conversion to fibrin, which prevents new clots from developing and existing clots from expanding. Its fast-acting properties establish it as the primary method for emergency blood-thinning treatment, which hospitals use.
HEPARCHEM 25000 IU has many therapeutic and preventative uses:
Store the vials at temperatures of 30°C or below. Do not freeze. Store the container in the original package to guard against effects from humidity and changes in temperature.
A: This format is important to hospital workflows as it allows for the timely preparation of IV drips for various rates of infusion for systemic anticoagulation.
A: The sodium salt guarantees the drug’s high solubility, rapid availability, and instantaneous systemic effect after IV administration, enabling the patient to experience the impact of the anticoagulant almost immediately.
A: The large anticoagulant activity of the drug can lead to large, painful hematomas with tissue damage and unpredictable absorption when injected intramuscularly.
A: We use USP Type-I borosilicate glass to prevent leaching of the product and ensure that the active and delicate heparin molecules are stable and potent until the product expires.
A: Heparin is usually made from porcine intestinal mucosa, so patients with allergies should be assessed by an immunologist if necessary before using.
A: High doses of heparin must be administered in major surgical procedures to prevent clotting within the bypass machine; this concentration can be administered quickly at high concentrations without additional fluid.
A: The aPTT needs to be closely monitored after the procedure, as a rebound effect may occur, requiring an additional dose of protamine.
A: A small red bump or a small hard lump may develop. This can be avoided with site rotation to prevent tissue trauma and irritation.